StonvexLoading…
StonvexStonvexStonvexCore line items from DLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.13B | $2.12B | $2.19B | $2.24B |
Operating Income | $232.40M | $192.20M | $160.80M | $169.45M |
Net Income | $82.10M | $52.80M | $26.10M | $65.39M |
EPS (Diluted) | $1.80 | $1.18 | $0.59 | $1.50 |
Total Assets | $2.86B | $2.83B | $3.08B | $3.08B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $36.90M | $34.40M | $72.00M | $40.44M |
Free Cash Flow OCF − CapEx | $175.30M | $100.00M | $97.70M | Not available |
Shares Outstanding | 45.00M | 44.30M | 43.70M | 43.20M |